EGFR and triple-negative breast carcinoma: For instance, in triple-negative breast cancer treatment, hyaluronic acid–chitosan was built to deliver miR-34a mimics [144], and RNA-NPs (nanoparticles) decorated with EGFR-targeting aptamer, which was used to carry a miR-21 inhibitor [145].